Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01+0.03 (+3.30%)
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Cocrystal Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cocrystal Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.95M. For fiscal 2025 it was -$8.19M. The highest annual figure on record is -$261.42K in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.19M | – |
| FY2024 | Dec 31, 2024 | -$16.49M | – |
| FY2023 | Dec 31, 2023 | -$14.67M | – |
| FY2022 | Dec 31, 2022 | -$21.44M | – |
| FY2021 | Dec 31, 2021 | -$12.72M | – |
| FY2020 | Dec 31, 2020 | -$9.83M | – |
| FY2019 | Dec 31, 2019 | -$1.56M | – |
| FY2018 | Dec 31, 2018 | -$8.29M | – |
| FY2017 | Dec 31, 2017 | -$6.90M | – |
| FY2016 | Dec 31, 2016 | -$14.66M | – |
| FY2015 | Dec 31, 2015 | -$10.32M | – |
| FY2014 | Dec 31, 2014 | -$6.01M | – |
| FY2013 | Dec 31, 2013 | -$3.69M | – |
| FY2012 | Dec 31, 2012 | -$1.59M | – |
| FY2011 | Dec 31, 2011 | -$420.95K | – |
| FY2010 | Dec 31, 2010 | -$261.42K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.52M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.74M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.16M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.70M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.33M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.68M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.40M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.77M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.38M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.20M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.19M | -208.4% |
| Q4 FY2019 | Dec 31, 2019 | -$1.23M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.32M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.03M | – |
| Q1 FY2019 | Mar 31, 2019 | $2.02M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.97M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.09M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.08M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.58M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.19M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.30M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.15M | – |
See a number that looks wrong?